News/Events

Stay up to date with our latest news and events.

Medium-throughput Antibody Production

Medium-throughput Antibody Production

6/29/2017

Proteos is a leader in customized recombinant antibody production offering production of full-length IgG, F(ab) and (Fab’)2 antibody fragments, and antibody fusion proteins.  It is often beneficial for researchers to produce multiple antibodies simultaneously for functional screening studies.  This type of production can be prohibitive at large scales due to cost constraints and at very small scales due to low production yields.  Proteos provides researchers a solution with our medium-throughput antibody production service.

Tags: antibody, Antibody Production, Monoclonal Antibodies

Proteos Enters Co-Marketing Agreement with Protea Biosciences

Proteos Enters Co-Marketing Agreement with Protea Biosciences

5/4/2017

Proteos, Inc. and Protea Biosciences Group, Inc. announced today that they have entered into a joint co-marketing agreement.  This mutual partnership allows Protea to combine Proteos' protein production capabilities alongside Protea's proprietary bioanalytical services, and allows Proteos to market and promote Protea's proprietary bioanalytical services with their custom protein production services

Tags: mass spectrometry, Protea Biosciences

PEGS Boston 2017 – Proteos Booth # 321 – May 1-5

4/26/2017

Proteos will be exhibiting at the Protein Engineering Summit (PEGS Boston).  Please stop by booth #321 to meet with our company President, Dr. Al Darzins and learn why Proteos is an industry leader in the production of high-quality recombinant proteins and antibodies.

Tags: PEGS

Antibody, IgG (immunoglobulin), antibody labeling, monoclonal antibodies

Advance Your Research with High-quality Monoclonal Antibody Labeling

3/28/2017

High-quality labeled antibodies are crucial for many research applications including Western blotting, ELISA, immunofluorescence, immunohistochemistry, and flow cytometry. Specialized conjugates are not always commercially available but can be custom produced to your specifications at Proteos.

Tags: Antibody labeling, Antibody Production, Monoclonal Antibodies

Insect Cell Expression

Ensure Reproducible Insect Cell Expression with Accurate Baculovirus Titers

1/23/2017

An accurate baculovirus titer is essential for optimal insect cell expression and reproducibility. Proteos offers a rapid, economical flow cytometry assay for titer determination. 

Tags: baculovirus expression, insect cell expression, services

Alpha-synuclein Research Tools poster co-authored by Lindsey Gottler, PhD., Proteos’ Director of Protein Purification

12/7/2016

The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology presented at Neuroscience 2016.

Tags: Alpha-synuclein, MJFF, Parkinson's

Neuroscience 2016 – Michael J. Fox Foundation Poster Presentation - Research tools for Parkinson’s disease

11/11/2016

The Michael J. Fox Foundation will be presenting a poster at this year’s conference describing the research tools program:  The Michael J. Fox Foundation's Strategy to Generate, Characterize, and Distribute Preclinical Alpha-Synuclein Research Tools for Molecular Biology

Tags: MJFF, neuroscience, Parkinson's

Neuroscience 2016 – November 12-16 – San Diego, CA

11/4/2016

Proteos will be exhibiting at Neuroscience 2016.  Please stop by booth 4304 to meet us and learn why we are an industry leader in the production of recombinant proteins and antibodies.

Tags: neuroscience, Parkinson's

Neuroscience 2016

Proteos, Inc. to Attend Neuroscience 2016, November 12 to 16 in San Diego

8/8/2016

Celebrating over 30,000 attendees from over 80 countries, the Society for Neuroscience's (SfN) annual meeting is the world's premier destination for anyone seeking ideas and tools related to the field. With members able to view more than 15,000 abstracts, explore countless exhibits and network with other professionals in the field, the meeting aims to assist neuroscience professionals at all stages of their careers.

Tags: neuroscience

Michael J. Fox Foundation

Michael J. Fox Foundation Announces Library of Available Recombinant DJ-1 Proteins in Collaboration with Proteos

8/5/2016

The Michael J. Fox Foundation (MJFF) first goal is to propel breakthroughs that Parkinson's sufferers can immediately feel in their day to day lives. The foundation realizes the importance of protein reagents in many applications related to treating Parkinson's disease. MJFF has partnered with Proteos who provides them with the best quality reagents to support research of Parkinson's disease.

Tags: DJ-1, MJFF